University of California San Francisco
Give to UCSF
A team of cancer researchers led by scientists at UCSF and Memorial Sloan Kettering Cancer Center in New York have developed a first-of-its-kind hybrid drug with the power to outsmart drug-resistant cancers.
Exciting advances in medicine and health are being researched in precision medicine projects recently funded by the George and Judy Marcus Program in Precision Medicine Innovation.
Time magazine has named internationally renowned breast cancer oncologist Laura Esserman to the 2016 TIME 100, the magazine’s annual list of the 100 most influential people in the world.
The new UCSF Center for BRCA Research – which spans basic and translational research, clinical care and education – provides a one-stop resource for patients and individuals who carry BRCA1 and BRCA2 mutations.
UCSF researchers have discovered that the chances of survival for patients with pancreatic adenocarcinoma (PDAC) — the most common type of pancreatic cancer — may depend in part on how tense their tumors are.
Oncologist Lawrence Fong is leading UCSF’s newly launched Cancer Immunotherapy Program, a clinic and laboratory dedicated to developing and studying cutting-edge immunotherapy treatments.
Renowned UCSF immunologist Jeffrey Bluestone, PhD, has been named president and CEO of the Parker Institute for Cancer Immunotherapy, a national initiative launched with a $250 million grant from The Parker Foundation, established by Silicon Valley entrepreneur Sean Parker.
Bruce Alberts has been named one of the 11 newly elected fellows of the American Association for Cancer Research.
Mitchel Berger and Jeff Bluestone have been named to a Blue Ribbon Panel of scientific experts, cancer leaders and patient advocates that will help to guide the National Cancer Moonshot Initiative.
Eleni Linos and Stephen Francis have been awarded the first UCSF Cancer Center Impact Grants, to pursue high-risk, high-reward research projects that would’ve been unlikely to be funded through conventional mechanisms.
Scientists at UC San Francisco have been able to directly observe, for the first time, how invasive cancer cells create a beachhead as they migrate to the lung in a mouse model of metastatic cancer.
UCSF announced the establishment of the Quantitative Biosciences Institute (QBI), to drive forward the application of computation, mathematics, and statistics toward a deeper understanding of complex problems in biology.
The most intractable common form of breast cancer might in most cases be treatable by drugs that target fat metabolism, according to UCSF researchers.
Life-or-death verdicts in cancer often result from the ways microscopic kinks and folds in proteins fit together within a tumor cell. While in college, Trever Bivona was fascinated by the idea that a single protein’s twists could determine the trajectory of the disease.
Vice President Joe Biden and his wife Jill Biden visited UCSF to meet with top cancer experts as part of the National Cancer Moonshot initiative to develop new approaches that fast-forward the development of novel therapies.
UCSF researchers are using big data to find cancer treatments by mapping gene networks and screening existing cancer drugs to test their effectiveness against dozens of different cancer gene variants.
UCSF scientists have created a new class of highly customizable biological sensors that can be used to form “logic gates” inside cells of the immune system, giving these cells the capability to home in on and kill a wide range of cancer cells while preventing them from attacking normal tissue.
What if screening for cancer was as easy as checking your cholesterol? That’s the promise of techniques currently in development that may one day make it possible to detect the earliest stages of cancer with an annual blood draw.
Twice as many patients with non-serious injuries, such as fractures or neck strain, are undergoing CT scans in emergency departments at California hospitals, according to a UCSF-led study, which tracked the use of the imaging from 2005 to 2013.
We asked experts across UCSF to identify what's ahead in how we approach research, what disease areas will see major advances, and where basic science will be translating into real treatments.
The lineup is finalized for the 2016 Personalized Medicine World Conference, with nine scheduled talks by UCSF leaders and faculty.
